261 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
New Zealand Posts NZ$323 Million Trade Deficit https://www.rttnews.com/3419638/new-zealand-posts-nz-323-million-trade-deficit.aspx?type=alleco Jan 28, 2024 - New Zealand had a merchandise trade deficit of NZ$323 million in December, Statistics New Zealand said on Monday.
GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost https://www.cnbc.com/2024/01/31/gsk-posts-blowout-rsv-vaccine-sales-raises-outlook.html Jan 31, 2024 - The RSV shot, called Arexvy, booked £1.2 billion, or $1.5 billion, in sales after only being on the market for roughly half a year.
Bristol Myers Squibb results top estimates as new drugs post strong sales growth https://www.cnbc.com/2024/02/02/bristol-myers-squibb-bmy-q4-earnings-report-2023.html Feb 02, 2024 - Bristol Myers Squibb also issued its full-year 2024 forecast, which was generally in line with expectations.
Gilead set to roll out Q4 results post-market Tuesday https://seekingalpha.com/news/4062948-earnings-preview-gilead-set-to-roll-out-q4-results-post-market-tuesday?source=feed_sector_healthcare Feb 05, 2024 - Gilead Sciences (GILD) is expected to report a higher Q4 2023 profit on lower revenue after market close on Tuesday. Read more here.
AIM stock dips amid mixed results for post-COVID fatigue therapy https://seekingalpha.com/news/4064686-aim-stock-dips-amid-mixed-results-for-post-covid-fatigue-therapy?source=feed_sector_healthcare Feb 08, 2024 - AIM ImmunoTechn (AIM) stock dipped after the company reported mixed topline results from a Phase 2 study of Ampligen for post-COVID fatigue. Read more here.
Medtronic Q3 in focus amid MedTech’s post-COVID gains https://seekingalpha.com/news/4068521-medtronic-q3-in-focus-amid-medtechs-gains?source=feed_sector_healthcare Feb 18, 2024 - Medtronic is set to report its Q3 FY24 results, with high expectations following strong performances from its peers in the MedTech sector. Read more here.
HSBC posts record annual profit but misses estimates on China write-down, shares tumble 7% https://www.cnbc.com/2024/02/21/hsbc-pre-tax-annual-profit-jumps-78percent-misses-market-estimates.html Feb 21, 2024 - The London-based lender suffered a "valuation adjustment" of $3 billion on its stake in Bank of Communications.
Moderna to preview post COVID prospects in Q4 results https://seekingalpha.com/news/4069812-moderna-to-preview-post-covid-prospects-q4?source=feed_sector_healthcare Feb 21, 2024 - Moderna (MRNA) is set to release its Q4 2023 results, with investors focused on how the vaccine maker will address its post-COVID growth concerns. Read more here.
Foot Locker shares plunge nearly 30% as retailer posts holiday loss, delays key financial target https://www.cnbc.com/2024/03/06/foot-locker-fl-earnings-q4-2023.html Mar 06, 2024 - Foot Locker reported earnings as CEO Mary Dillon leads the legacy retailer through an ambitious turnaround. But some analysts say it has gone too slowly.
CASI Pharma Posts Positive BI-1206 Interim Phase 1 Data In R/R INHL; Stock Climbs In Pre-market https://www.rttnews.com/story.aspx?Id=3429895 Mar 05, 2024 - Shares of CASI Pharmaceuticals, Inc. (CASI) were gaining more than 49 percent in pre-market activity on Nasdaq after the biopharmaceutical company announced Tuesday positive interim Phase 1 Data for BI-1206 (Anti-FcyRIIB antibody) in patients with relapsed/refractory or R/R indolent Non-Hodgkin's Lymphoma or iNHL.

Pages: 1234567891011...27

<<<Page 6>